Overview
Cannabinoids and Cerebellar-Motor Functioning
Status:
Active, not recruiting
Active, not recruiting
Trial end date:
2021-12-01
2021-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to characterize the dose-related effects of delta-9-tetrahydrocannabinol (∆9-THC) in healthy individuals on cerebellum-dependent motor functions.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Yale UniversityTreatments:
Ethanol
Criteria
Inclusion Criteria:- Must have used cannabis at least once in their lifetime
- No cannabis use in the past month
- Men and women aged 21 to 35 years (extremes included) on the day of the first dosing
Exclusion Criteria:
- Hearing deficits
- Psychiatric or mental disorders
- Hearing Deficits